Advisors Asset Management Inc. Boosts Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Advisors Asset Management Inc. grew its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 8.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,123,668 shares of the pharmacy operator's stock after purchasing an additional 91,551 shares during the quarter. Advisors Asset Management Inc. owned approximately 0.13% of Walgreens Boots Alliance worth $10,484,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Kennondale Capital Management LLC acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at $1,050,000. Signaturefd LLC increased its position in shares of Walgreens Boots Alliance by 12.3% in the 4th quarter. Signaturefd LLC now owns 15,417 shares of the pharmacy operator's stock worth $144,000 after purchasing an additional 1,692 shares during the last quarter. Cibc World Markets Corp increased its position in shares of Walgreens Boots Alliance by 15.2% in the 4th quarter. Cibc World Markets Corp now owns 282,286 shares of the pharmacy operator's stock worth $2,634,000 after purchasing an additional 37,141 shares during the last quarter. Harbour Investments Inc. boosted its holdings in shares of Walgreens Boots Alliance by 4.3% in the 4th quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock valued at $265,000 after buying an additional 1,165 shares during the period. Finally, Corient Private Wealth LLC boosted its holdings in shares of Walgreens Boots Alliance by 4.0% in the 4th quarter. Corient Private Wealth LLC now owns 282,798 shares of the pharmacy operator's stock valued at $2,639,000 after buying an additional 10,772 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

A number of analysts have commented on WBA shares. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price objective for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research report on Monday, January 13th. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Finally, Royal Bank of Canada increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Stock Down 0.2 %

Shares of WBA traded down $0.02 during trading hours on Friday, reaching $11.10. The stock had a trading volume of 37,249,707 shares, compared to its average volume of 20,761,826. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05. The firm has a 50-day simple moving average of $10.96 and a 200 day simple moving average of $9.82. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $9.59 billion, a price-to-earnings ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm's revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.66 EPS. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.